Teva Pharmaceuticals

Teva Pharmaceutical Industries is a global biopharmaceutical company headquartered in Israel and one of the world’s leading manufacturers of generic medicines. The company develops, manufactures, and markets a broad portfolio of generic medicines, biosimilars, and innovative pharmaceutical products.
Teva has a long history in the pharmaceutical industry, with its origins dating back to 1901 in Jerusalem. Over the years, the company has expanded internationally and established a significant presence across pharmaceutical markets worldwide.
In addition to its extensive generic medicines portfolio, Teva focuses on innovative treatments in therapeutic areas including neuroscience and immunology. The company also develops biosimilars intended to increase access to biological medicines and provide more affordable treatment options.
Teva’s activities cover various stages of the pharmaceutical lifecycle, including research and development, regulatory approval, manufacturing, commercialization, and intellectual property management. The company maintains a substantial global patent portfolio and is involved in patent litigation and other intellectual property matters concerning pharmaceutical products.
Teva Pharmaceuticals is therefore an important company in the context of generic and biosimilar medicines, pharmaceutical patents, patent litigation, regulatory data exclusivity, and intellectual property strategies relating to market entry and pharmaceutical commercialization.